/Investor DB

MAIF Avenir — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Bluebird Biobluebirdbio.com𝕏Sep 2021Acquired

Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.

BiotechLongevityMedical DevicesCambridge, US

David Meek(CEO)inBrian Riley(President & Chief Technical Officer)inJoanne Lager(Chief Medical Officer)inWendy DiCicco(Chief Financial Officer)inAdrian Chaisson(Chief of Staff)inJason Cole(Executive Officer)

Co-investorsARCH Venture PartnersEaston CapitalHercules Capital, Inc.RA CapitalRitual CapitalSanofi Ventures+4 more

Maydaymayday.aminJul 2021

Mayday was a productivity software company focused on calendar and time management that emphasized empathy and coordination of shared time demands.

AI & Machine LearningFuture of WorkSaaSWellness & FitnessToronto, CA

Diana Lau(Founder)in

Co-investorsColle Capital PartnersTechstarsPanache Ventures

Maydaygetmayday.cominJul 2021

Mayday automates month-end accounting workflows for finance teams using Xero or QuickBooks, eliminating manual work and errors while providing ERP-level insights.

AI & Machine LearningEnterprise SoftwareFintechSaaS

David(Founder & CEO)Griff(Co-founder)

Co-investorsFlying Fox VenturesVentures TogetherFalak Startups

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.